Since myocardial fibrosis is widespread in DCM and a rise in CTGF levels often before clinical indications of cardiac fibrosis, the CTGF test is relevant in evaluating myocardial fibrosis and its prognosis [131]. This evidence concerns the gene CCN2 and familial dilated cardiomyopathy.